Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (SHA:688336)
73.07
-0.12 (-0.16%)
May 6, 2026, 3:00 PM CST
SHA:688336 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 282.57 | 193.27 | 459.49 | 933.26 | 1,091 | 1,614 |
Short-Term Investments | - | 4,488 | 863.59 | 344.19 | - | - |
Trading Asset Securities | 1,192 | 1,074 | 910.54 | 603.87 | 1,486 | 752.05 |
Cash & Short-Term Investments | 1,475 | 5,755 | 2,234 | 1,881 | 2,577 | 2,366 |
Cash Growth | -14.58% | 157.63% | 18.73% | -27.00% | 8.93% | -14.31% |
Accounts Receivable | 309.8 | 153.84 | 147.14 | 133.24 | 149.35 | 256.97 |
Other Receivables | 0.11 | 0.16 | 0.03 | 0.2 | 0.29 | 0.53 |
Receivables | 309.91 | 154 | 147.17 | 133.44 | 149.65 | 257.5 |
Inventory | 279.63 | 260.55 | 229.6 | 194.96 | 227 | 210.14 |
Other Current Assets | 4,028 | 60.21 | 49.64 | 40.09 | 32.54 | 38.09 |
Total Current Assets | 6,092 | 6,229 | 2,660 | 2,250 | 2,986 | 2,872 |
Property, Plant & Equipment | 1,534 | 1,534 | 1,539 | 1,562 | 1,426 | 1,371 |
Long-Term Investments | 98.02 | 442.73 | 1,140 | 1,020 | 109.4 | 122.37 |
Goodwill | 0.64 | 0.64 | 0.64 | 0.64 | 0.64 | 0.64 |
Other Intangible Assets | 317.2 | 208.75 | 223.96 | 240.16 | 195.73 | 196.55 |
Long-Term Deferred Tax Assets | 127.83 | 125.98 | 129.62 | 145.74 | 173.43 | 155.31 |
Long-Term Deferred Charges | 239.65 | 341.94 | 228.54 | 44.44 | 114.02 | 97.67 |
Other Long-Term Assets | 538.59 | 74.35 | 43.68 | 42.16 | 92.76 | 73.59 |
Total Assets | 8,948 | 8,957 | 5,965 | 5,305 | 5,098 | 4,889 |
Accounts Payable | 40.7 | 34.96 | 34.96 | 21.93 | 15.91 | 16.27 |
Accrued Expenses | 39.87 | 172.13 | 174.93 | 181.2 | 56.18 | 127.71 |
Short-Term Debt | - | - | 50.02 | 50.03 | 150.1 | - |
Current Income Taxes Payable | 10.92 | 141.29 | - | 1.3 | 1.2 | 0.21 |
Current Unearned Revenue | 34.12 | 62.1 | 20.2 | 16.77 | 19.55 | 3.25 |
Other Current Liabilities | 151.44 | 36.54 | 36.8 | 36.91 | 132.15 | 68.01 |
Total Current Liabilities | 277.05 | 447.02 | 316.91 | 308.14 | 375.09 | 215.45 |
Long-Term Unearned Revenue | 90.97 | 95.6 | 111.24 | 118.33 | 123.79 | 134.28 |
Total Liabilities | 368.01 | 542.62 | 428.15 | 426.47 | 498.88 | 349.73 |
Common Stock | 618.09 | 618.09 | 616.79 | 616.79 | 616.79 | 616.21 |
Additional Paid-In Capital | 2,396 | 2,386 | 2,310 | 2,303 | 2,309 | 2,301 |
Retained Earnings | 5,640 | 5,462 | 2,639 | 1,985 | 1,691 | 1,641 |
Comprehensive Income & Other | -34.29 | -13.58 | 2.44 | -8.71 | -10.67 | -17.33 |
Total Common Equity | 8,620 | 8,453 | 5,568 | 4,896 | 4,606 | 4,542 |
Minority Interest | -39.77 | -38.21 | -30.76 | -17.58 | -6.32 | -2.46 |
Shareholders' Equity | 8,580 | 8,415 | 5,537 | 4,879 | 4,600 | 4,539 |
Total Liabilities & Equity | 8,948 | 8,957 | 5,965 | 5,305 | 5,098 | 4,889 |
Total Debt | - | - | 50.02 | 50.03 | 150.1 | - |
Net Cash (Debt) | 1,475 | 5,755 | 2,184 | 1,831 | 2,427 | 2,366 |
Net Cash Growth | -12.03% | 163.53% | 19.24% | -24.55% | 2.59% | -14.31% |
Net Cash Per Share | 2.37 | 9.29 | 3.53 | 2.98 | 3.94 | 3.93 |
Filing Date Shares Outstanding | 614.2 | 618.09 | 616.79 | 616.79 | 616.79 | 616.21 |
Total Common Shares Outstanding | 614.2 | 618.09 | 616.79 | 616.79 | 616.79 | 616.21 |
Working Capital | 5,815 | 5,782 | 2,343 | 1,942 | 2,611 | 2,656 |
Book Value Per Share | 14.03 | 13.68 | 9.03 | 7.94 | 7.47 | 7.37 |
Tangible Book Value | 8,302 | 8,244 | 5,343 | 4,655 | 4,409 | 4,344 |
Tangible Book Value Per Share | 13.52 | 13.34 | 8.66 | 7.55 | 7.15 | 7.05 |
Buildings | - | 818.98 | 626.77 | 626.77 | 531.48 | 531.48 |
Machinery | - | 1,333 | 1,220 | 1,196 | 1,043 | 1,035 |
Construction In Progress | - | 544.11 | 749.65 | 687.81 | 717.11 | 572.47 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.